Tus-Pharmaceutical Group Co., Ltd.

Shenzhen Stock Exchange 000590.SZ

Tus-Pharmaceutical Group Co., Ltd. Price to Sales Ratio (P/S) on January 27, 2025: 4.00

Tus-Pharmaceutical Group Co., Ltd. Price to Sales Ratio (P/S) is 4.00 on January 27, 2025, a -16.56% change year over year. Price to sales ratio compares the stock price to the sales per share; higher suggests positive sentiment for future revenue growth.

Tus-Pharmaceutical Group Co., Ltd. 52-week high Price to Sales Ratio (P/S) is 5.56 on November 25, 2024, which is 39.05% above the current Price to Sales Ratio (P/S).
Tus-Pharmaceutical Group Co., Ltd. 52-week low Price to Sales Ratio (P/S) is 2.83 on July 24, 2024, which is -29.10% below the current Price to Sales Ratio (P/S).
Tus-Pharmaceutical Group Co., Ltd. average Price to Sales Ratio (P/S) for the last 52 weeks is 3.81.

Key data

Date	Price to Sales Ratio (P/S)	Price to Book Ratio (P/B)	Dividend Yield	Free Cash Flow Yield

Shenzhen Stock Exchange: 000590.SZ

Tus-Pharmaceutical Group Co., Ltd.

CEO	Ms. Ting Tang
IPO Date	Jan. 19, 1996
Location	China
Headquarters	No. 33, Yangliu Road
Employees	1,237
Sector	Healthcare
Industries Pharmaceuticals Biotechnology Cleaning Supplies Consumer Packaged Goods Cosmetics Drugstores & Retail Pharmacies Personal Care Tobacco

Description

Tus-Pharmaceutical Group Co., Ltd. manufactures and sells traditional Chinese medicine and western medicine products. The company was formerly known as Tus-Guhan Group Corp.,Ltd. Tus-Pharmaceutical Group Co., Ltd. was founded in 1956 and is based in Hengyang, China.

Key trends

Past 5 years